Consequently, those with type 1 diabetes must administer insulin for the rest of their lives to regulate blood sugar levels. In some people with type 1 diabetes, long-term use of ...
News-Medical.Net on MSN
How diabetes medications may influence cancer risk and progression
Diabetes, particularly Type 2 Diabetes (T2DM), has been linked to an increased risk of various cancers, including liver, colorectal, and breast cancer.
This research delves into the association between anti-diabetic medications and cancer, exploring mechanisms beyond just ...
South Korean researchers have scientifically identified the cause of the concentration and memory loss symptoms reported ...
A cheap, century-old medication can improve life for people with type 1 diabetes, according to new research. A clinical trial in Australia found that type 2 diabetes drug metformin reduces insulin ...
At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...
Daily Express US on MSN
Diabetes breakthrough as century-old medicine 'helps manage type 1 diabetes'
A clinical trial found that metformin, a drug typically used for type 2 diabetes, reduced insulin requirements by around 12% in adults with type 1 diabetes.
Recent research reveals that metformin, a long-used diabetes drug, may function through the brain more than previously believed. Scientists found out that the medication reaches the ventromedial ...
With the skyrocketing popularity of GLP-1 RAs, some lesser-known side effects, including anemia, are coming to light.
Humanity has long been captivated by the idea of immortality, a desire to defy aging and death. While myths and literature ...
At ASN Kidney Week 2025, Glucagon-like peptide-1 (GLP-1) receptor agonists moved firmly into the nephrology spotlight, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results